Glusimet tablets is primarily indicated in conditions like Type Il diabetes mellitus.
The severe or irreversible adverse effects of Glusimet tablets, which give rise to further complications include Fever, Pancreatitis, Hypersensitivity reactions, Chills, Peeling & redness of skin., Glusimet tablets produces potentially life-threatening effects which include Hypoglycemia, Hypoglycemia, Pancreatitis. which are responsible for the discontinuation of Glusimet tablets therapy., The signs and symptoms that are produced after the acute overdosage of Glusimet tablets include Tachycardia, Coma, Seizures, Drowsiness, Confusion, Hypoglycemia, Dizziness, Fainting, Sweating, Headache, Irritability, Tremor, Weakness.,The symptomatic adverse reactions produced by Glusimet tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache. Nausea. Diarrhea, Sore throat, Stomach upset, Stuffy nose.
Glusimet tablets is contraindicated in conditions like Trauma, Diabetic ketoacidosis, Type I diabetes mellitus, Insulin dependent diabetes mellitus, Severe infections.
Patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Glusimet tablets should promptly be discontinued and appropriate management should be initiated. A dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with ESRD requiring hemodialysis or peritoneal dialysis. Use caution when used in conjunction with sulfonylureas; risk of hypoglycemia is increased. Monitor blood glucose closely; dosage adjustments of the sulfonylurea may be necessary. Safety and efficacy have not been established in children <18 years of age.